+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bradycardia Drug"

Bradycardia Treatment Devices Market Report 2024 - Product Thumbnail Image

Bradycardia Treatment Devices Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
From
Heart Blocks Treatment Devices Market Report 2025 - Product Thumbnail Image

Heart Blocks Treatment Devices Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Bradycardia is a type of cardiac arrhythmia characterized by a slow heart rate. Bradycardia drugs are used to treat this condition and are part of the larger cardiovascular drug market. These drugs work by increasing the heart rate and restoring normal rhythm. Commonly used bradycardia drugs include beta-blockers, calcium channel blockers, and pacemaker drugs. Beta-blockers are used to reduce the workload on the heart and slow the heart rate. Calcium channel blockers are used to reduce the force of contraction of the heart muscle and slow the heart rate. Pacemaker drugs are used to stimulate the heart and restore normal rhythm. The bradycardia drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies include AstraZeneca, Bristol-Myers Squibb, and Boehringer Ingelheim. Show Less Read more